Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | News
Search Refinements

Contract Research News

View news from other Pharmaceutical sectors:
31-45 of 2112 results
Bristol-Myers to test Opdivo with Nektar Therapeutics drug in five tumor types
By PBR Staff Writer
Bristol-Myers Squibb (BMS) is evaluating the use of its cancer immunotherapy, Opdivo, in combination with an experimental drug from Nektar Therapeutics to treat several cancers.
Contract Research & Services > Contract Research > News
Evotec forms research collaboration with Inserm Transfert in oncology
Evotec has entered into a research collaboration with Inserm Transfert, the private subsidiary of the French National Institute of Health and Medical Research (Inserm).
Contract Research & Services > Contract Research > News
Takeda, Affilogic partner to develop CNS therapies
Takeda Pharmaceutical Company and Affilogic have entered into a research collaboration to explore using Affilogic’s Nanofitins platform in therapies targeting the central nervous system (CNS).
Contract Research & Services > Contract Research > News
Bayer, Evotec join hands to develop new treatments for kidney diseases
By PBR Staff Writer
Bayer and German firm Evotec have partnered to develop to new treatments for kidney diseases.
Contract Research & Services > Contract Research > News
Redx Pharma confirms potential role for Porcupine inhibitor in cancer immunotherapy
Redx Pharma has confirmed that its lead cancer treatment, the Porcupine inhibitor (RXC004), has a potential role in cancer immunotherapy.
Contract Research & Services > Contract Research > News
Sanofi, Verily Life Sciences create new JV to develop diabetes management platform
By PBR Staff Writer
French pharmaceutical firm Sanofi and Alphabet subsidiary Verily Life Sciences have launched a new joint venture (JV) called Onduo, to develop comprehensive diabetes management platform.
Contract Research & Services > Contract Research > News
Biothera collaborates with Merck for combination cancer immunotherapy trials in multiple indications
Biothera Pharmaceuticals announced a collaboration with Merck to expand the companies’ ongoing clinical program evaluating KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 inhibitor, in combination with Biothera’s Imprime PGG, a Pathogen Associated Molecular Patterning molecule, or PAMP.
Contract Research & Services > Contract Research > News
Xycrobe signs research deal with Johnson & Johnson Consumer
Xycrobe Therapeutics has entered into a research agreement with Johnson & Johnson Consumer.
Contract Research & Services > Contract Research > News
Abeona, EBRP and EB MRF to collaborate on epidermolysis bullosa treatments
Abeona Therapeutics, EB Research Partnership (EBRP) and EB Research Medical Foundation (EBMRF) announced a collaboration focusing on gene therapy treatments for epidermolysis bullosa (EB), a group of devastating rare genetic skin disorders impacting children; characterized by skin blisters and erosions all over the body.
Contract Research & Services > Contract Research > News
Proteostasis completes preclinical milestone in collaboration with Astellas Pharma
Proteostasis Therapeutics has completed a key preclinical milestone in its collaboration with Astellas Pharma.
Contract Research & Services > Contract Research > News
Codexis completes obligations under research and development deal with biopharmaceutical firm
Codexis has completed its obligations under a collaborative research and development agreement with a leading global biopharmaceutical company.
Contract Research & Services > Contract Research > News
Pfizer, Western Oncolytics establish immuno-oncology research collaboration
Pfizer and Western Oncolytics have entered into a development collaboration, license and option agreement to advance Western Oncolytics’ novel oncolytic vaccinia virus, WO-12.
Contract Research & Services > Contract Research > News
Bristol-Myers Squibb, Janssen collaborate on lung cancer treatment
By PBR Staff Writer
Bristol-Myers Squibb (BMS) and Janssen Biotech have signed a clinical study collaboration agreement to evaluate the combination of two immuno-oncology compounds in patients with non-small cell lung cancer (NSCLC).
Contract Research & Services > Contract Research > News
AbbVie, Bristol-Myers Squibb partner on combo treatment for lung cancer
By PBR Staff Writer
AbbVie and Bristol-Myers Squibb (BMS) are collaborating on a clinical trial combining both companies’ checkpoint inhibitors to treat relapsed extensive-stage small cell lung cancer (SCLC).
Contract Research & Services > Contract Research > News
Tiziana acquires bio-repository from Shardna
By PBR Staff Writer
UK-based clinical stage biotechnology company Tiziana Life Sciences has acquired the genetic data of about 13,000 people from the Ogliastra region of Sardinia.
Contract Research & Services > Contract Research > News
31-45 of 2112 results